Chemoinformaics analysis of 4-Methoxyamphetamine
| Molecular Weight | 165.236 | nRot | 3 |
| Heavy Atom Molecular Weight | 150.116 | nRig | 6 |
| Exact Molecular Weight | 165.115 | nRing | 1 |
| Solubility: LogS | -2.7 | nHRing | 0 |
| Solubility: LogP | 1.765 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 28.6039 |
| nHD | 1 | BPOL | 16.2141 |
| QED | 0.738 |
| Synth | 1.927 |
| Natural Product Likeliness | -0.021 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.272 |
| HIA | 0.006 |
| CACO-2 | -4.747 |
| MDCK | 0.0000549 |
| BBB | 0.825 |
| PPB | 0.344121 |
| VDSS | 5.23 |
| FU | 0.674248 |
| CYP1A2-inh | 0.711 |
| CYP1A2-sub | 0.893 |
| CYP2c19-inh | 0.142 |
| CYP2c19-sub | 0.923 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.375 |
| CYP2d6-inh | 0.954 |
| CYP2d6-sub | 0.922 |
| CYP3a4-inh | 0.076 |
| CYP3a4-sub | 0.465 |
| CL | 11.121 |
| T12 | 0.358 |
| hERG | 0.415 |
| Ames | 0.116 |
| ROA | 0.943 |
| SkinSen | 0.276 |
| Carcinogencity | 0.136 |
| EI | 0.027 |
| Respiratory | 0.945 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.892355 |